Beone Medicines Ltd. Class A · SSE:688235

Oyler John sold 109,713 Beone Medicines Ltd. Class A shares (Form 4)

Traded Jul 20 to Jul 21, 2026 · Filed Jul 22, 2026

From Jul 20 to Jul 21, 2026, Oyler John (Director, Chief Executive Officer) sold 109,713 Beone Medicines Ltd. Class A shares at an average US$315.29 for US$34.6M under a trading plan, leaving 0 shares. Filed Jul 22, 2026 (Form 4).

Sold
109,713 shares
Price
US$315.29 average (US$310.08 to US$320.06)
Value
US$34.6M
Holding after
0 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 20, 2026American Depositary SharesSale5,146US$310.089,180Direct
Jul 20, 2026American Depositary SharesSale6,273US$310.752,907Direct
Jul 20, 2026American Depositary SharesSale2,907US$311.800Direct
Jul 20, 2026American Depositary SharesOption exercise33,990US$119.9633,990Direct
Jul 20, 2026American Depositary SharesSale15,499US$312.2918,491Direct
Jul 20, 2026American Depositary SharesSale14,326US$312.964,165Direct
Jul 20, 2026American Depositary SharesSale1,850US$313.912,315Direct
Jul 20, 2026American Depositary SharesSale1,512US$315.26803Direct
Jul 20, 2026American Depositary SharesSale523US$316.14280Direct
Jul 20, 2026American Depositary SharesSale280US$318.300Direct
Jul 21, 2026American Depositary SharesSale15,379US$316.2646,018Direct
Jul 21, 2026American Depositary SharesSale20,029US$316.9125,989Direct
Jul 21, 2026American Depositary SharesSale7,842US$318.4118,147Direct
Jul 21, 2026American Depositary SharesSale15,807US$319.292,340Direct
Jul 21, 2026American Depositary SharesSale2,340US$320.060Direct

Source

View original at SEC

Related